Cargando…
Neuropsychiatric Disturbance in Huntington’s Disease: Approach to Management
INTRODUCTION: Huntington’s Disease (HD) is an autosomal dominant, neurodegenerative condition with a prevalence of 10.6-13.7 per 100,000, caused by the trinucleotide CAG (cytosine, adenine, guanine) repeat expansion in the HTT gene. HD is characterized by a range of motor, cognitive, and psychiatric...
Autores principales: | Jay, J., Kumar, V., Bidkhanian, P., Garrels, E., Segal, Y., Susaimanickam, B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9567710/ http://dx.doi.org/10.1192/j.eurpsy.2022.1208 |
Ejemplares similares
-
Neuropsychiatric Burden in Huntington’s Disease
por: Paoli, Ricardo Augusto, et al.
Publicado: (2017) -
Motivational Interviewing Technique As a Means of Decreasing Vaccine Hesitancy in Children and Adolescents During the COVID-19 Pandemic
por: Bidkhanian, P. A.
Publicado: (2023) -
Characterization of neuropsychiatric symptoms in a group of individuals with manifest or pre-motor Huntington’s disease in Medellín, Colombia
por: Vasquez, D., et al.
Publicado: (2022) -
Effects of the COVID-19 Pandemic on Social Determinants of Mental Health and Psychiatric Decompensation
por: Jay, J., et al.
Publicado: (2022) -
Neuroendocrine Disturbances in Huntington's Disease
por: Saleh, Nadine, et al.
Publicado: (2009)